Deprecated: Use of MediaWiki\Output\OutputPage::setIndexPolicy with index after noindex was deprecated in MediaWiki 1.43. [Called from MediaWiki\Output\OutputPage::setRobotPolicy in /home/forge/wikitrademarks.org/includes/Output/OutputPage.php at line 1008] in /home/forge/wikitrademarks.org/includes/debug/MWDebug.php on line 385
Category:Michelle Padgett of Kansas City MO (US) - WikiTrademarks Jump to content

Category:Michelle Padgett of Kansas City MO (US)

From WikiTrademarks
Revision as of 06:56, 30 March 2025 by Unknown user (talk) (Updating Category:Michelle_Padgett_of_Kansas_City_MO_(US))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Michelle Padgett of Kansas City MO (US)

Executive Summary

Michelle Padgett of Kansas City MO (US) is an inventor who has filed 2 patents. Their primary areas of innovation include for patient-specific data, e.g. for electronic patient records (2 patents), for the operation of medical equipment or devices (2 patents), for calculating health indices; for individual health risk assessment (2 patents), and they have worked with companies such as Cerner Innovation, Inc. (2 patents). Their most frequent collaborators include (2 collaborations), (2 collaborations), (2 collaborations).

Patent Filing Activity

File:Michelle Padgett of Kansas City MO (US) Monthly Patent Applications.png

Technology Areas

File:Michelle Padgett of Kansas City MO (US) Top Technology Areas.png

List of Technology Areas

  • G16H10/60 (for patient-specific data, e.g. for electronic patient records): 2 patents
  • G16H40/60 (for the operation of medical equipment or devices): 2 patents
  • G16H50/30 (for calculating health indices; for individual health risk assessment): 2 patents

Companies

File:Michelle Padgett of Kansas City MO (US) Top Companies.png

List of Companies

  • Cerner Innovation, Inc.: 2 patents

Collaborators

Subcategories

This category has the following 4 subcategories, out of 4 total.

Cookies help us deliver our services. By using our services, you agree to our use of cookies.